Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate if children with acute asthma given a
single dose of oral prednisolone with a subsequent daily five-day course of oral Montelukast
will achieve a therapeutic failure rate at day 8 not significantly higher than those given
six daily doses of oral prednisolone. Secondary objectives include comparison of the two
groups with respect to the changes in symptoms, beta2 agonists, clinical asthma score and
days without asthma by day 8.